Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

New antipsychotic agent goes head-to-head with established therapies

July 16, 1997

A new target for antiepileptic drugs

July 16, 1997

SB-242084: a potent and selective 5-HT2C receptor antagonist

July 16, 1997

Agents with affinity for central cannabinoid receptors reported by Sanofi

July 16, 1997

Efficacy of botulinum toxin type C in humans

July 15, 1997

Univ. of Pennsylvania team discovers new Alzheimer's lesion

July 15, 1997

MS&D reveals agents for migraine

July 15, 1997

Teva receives FDA approval for generic estazolam

July 15, 1997

NeoTherapeutics begins U.S. clinical trials of AIT-082

July 15, 1997

Mylan antianxiety/antipsychotic generic approved by FDA

July 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...